Arbutus Biopharma and Genevant Sciences File Patent
Companies seek compensation for Pfizer’s and BioNTech’s unlicensed use of patented technologies in COVID-19 mRNA-LNP vaccines WARMINSTER, Pa., April 04,...
Stay updated with breaking news from Genevant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Companies seek compensation for Pfizer’s and BioNTech’s unlicensed use of patented technologies in COVID-19 mRNA-LNP vaccines WARMINSTER, Pa., April 04,...
Arbutus Biopharma ABUS-Q on Tuesday sued U.S. drugmaker Pfizer Inc PFE-N and its German partner BioNTech SE BNTX-Q in a New Jersey district court, claiming…
Arbutus Biopharma on Tuesday sued U.S. drugmaker Pfizer Inc and its German partner BioNTech SE in a New Jersey district court, claiming their mRNA COVID-19 vaccines infringe five of Arbutus' patents.
Moderna will charge $130 for Covid vaccines, as though Americans haven’t paid enough already.
Added complexity, uncertain volume, and new responsibilities justify costs, chief executive says